Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 20/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22936148 | 0.91 | CD38 (0.74) | CD38 | |
| SCHEMBL22933178 | 0.87 | CD38 (0.72) | CD38 | |
| SCHEMBL29696451 | 0.87 | CD38 (0.72) | CD38 | |
| SCHEMBL29494883 | 0.87 | CD38 (0.79) | CD38 | |
| SCHEMBL22947055 | 0.87 | CD38 (0.82) | CD38 | |
| SCHEMBL22932674 | 0.87 | CD38 (0.79) | CD38 | |
| SCHEMBL22932676 | 0.87 | CD38 (0.79) | CD38 | |
| SCHEMBL29494917 | 0.87 | CD38 (0.82) | CD38 | |
| SCHEMBL22946904 | 0.86 | CD38 (0.75) | CD38 | |
| SCHEMBL22936508 | 0.86 | CD38 (0.85) | CD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431323-A | Heterobicyclic amides as CD38 inhibitors | 贝林格尔·英格海姆国际有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-114423753-B | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2024-09-17 | — | — | CN | disclosed |
| EP-4003980-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | Ribon Therapeutics Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-114423753-A | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2022-04-29 | — | — | CN | disclosed |